Connection

Dan Simionescu to Animals

Back to Details
This is a "connection" page, showing publications Dan Simionescu has written about Animals.
Dan Simionescu
Connection Strength
0.583
Animals
  1. Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System. Tissue Eng Part C Methods. 2015 Dec; 21(12):1284-96.
    View in: PubMed
    Score: 0.039
  2. Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts. Tissue Eng Part C Methods. 2014 Dec; 20(12):1016-27.
    View in: PubMed
    Score: 0.036
  3. The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models. Biomaterials. 2014 Aug; 35(24):6311-22.
    View in: PubMed
    Score: 0.035
  4. The acellular myocardial flap: a novel extracellular matrix scaffold enriched with patent microvascular networks and biocompatible cell niches. Tissue Eng Part C Methods. 2013 Jul; 19(7):518-30.
    View in: PubMed
    Score: 0.032
  5. Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies. Tissue Eng Part A. 2013 Apr; 19(7-8):952-66.
    View in: PubMed
    Score: 0.032
  6. Novel tissue-derived biomimetic scaffold for regenerating the human nucleus pulposus. J Biomed Mater Res A. 2011 Feb; 96(2):422-35.
    View in: PubMed
    Score: 0.028
  7. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A. 2011 Jan; 17(1-2):25-36.
    View in: PubMed
    Score: 0.027
  8. Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts. Tissue Eng Part A. 2009 Oct; 15(10):2837-51.
    View in: PubMed
    Score: 0.025
  9. Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A. 2009 Jun; 15(6):1257-68.
    View in: PubMed
    Score: 0.025
  10. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006 Feb; 27(5):702-13.
    View in: PubMed
    Score: 0.019
  11. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A. 2003 Sep 15; 66(4):755-63.
    View in: PubMed
    Score: 0.017
  12. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.016
  13. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 Mar; 12(2):226-34.
    View in: PubMed
    Score: 0.016
  14. Aortic valve disease in diabetes: Molecular mechanisms and novel therapies. J Cell Mol Med. 2021 10; 25(20):9483-9495.
    View in: PubMed
    Score: 0.015
  15. Challenges in Perioperative Animal Care for Orthotopic Implantation of Tissue-Engineered Pulmonary Valves in the Ovine Model. Tissue Eng Regen Med. 2020 12; 17(6):847-862.
    View in: PubMed
    Score: 0.014
  16. Integrins a4?1 and aV?3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease. Cell Transplant. 2020 Jan-Dec; 29:963689720946277.
    View in: PubMed
    Score: 0.013
  17. Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis. Diab Vasc Dis Res. 2019 11; 16(6):562-576.
    View in: PubMed
    Score: 0.013
  18. Pentagalloyl Glucose and Its Functional Role in Vascular Health: Biomechanics and Drug-Delivery Characteristics. Ann Biomed Eng. 2019 Jan; 47(1):39-59.
    View in: PubMed
    Score: 0.012
  19. Detergent-based decellularization strategy preserves macro- and microstructure of heart valves. Interact Cardiovasc Thorac Surg. 2018 02 01; 26(2):230-236.
    View in: PubMed
    Score: 0.011
  20. Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering. Tissue Eng Part A. 2016 11; 22(21-22):1241-1251.
    View in: PubMed
    Score: 0.010
  21. Manipulation of cellular spheroid composition and the effects on vascular tissue fusion. Acta Biomater. 2015 Feb; 13:188-98.
    View in: PubMed
    Score: 0.009
  22. Janus magnetic cellular spheroids for vascular tissue engineering. Biomaterials. 2014 Jan; 35(3):949-60.
    View in: PubMed
    Score: 0.008
  23. Biological magnetic cellular spheroids as building blocks for tissue engineering. Acta Biomater. 2014 Feb; 10(2):623-9.
    View in: PubMed
    Score: 0.008
  24. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves. J Biomed Mater Res. 1993 Jun; 27(6):697-704.
    View in: PubMed
    Score: 0.008
  25. Detection of remnant proteolytic activities in unimplanted glutaraldehyde-treated bovine pericardium and explanted cardiac bioprostheses. J Biomed Mater Res. 1993 Jun; 27(6):821-9.
    View in: PubMed
    Score: 0.008
  26. Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials. 2013 Jan; 34(3):685-95.
    View in: PubMed
    Score: 0.008
  27. Structural and biomechanical characterizations of porcine myocardial extracellular matrix. J Mater Sci Mater Med. 2012 Aug; 23(8):1835-47.
    View in: PubMed
    Score: 0.008
  28. Macrophage differentiation and polarization on a decellularized pericardial biomaterial. Biomaterials. 2011 Jan; 32(2):439-49.
    View in: PubMed
    Score: 0.007
  29. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A. 2010 Sep 15; 94(4):1100-10.
    View in: PubMed
    Score: 0.007
  30. Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease. Osteoporos Int. 2008 May; 19(5):625-35.
    View in: PubMed
    Score: 0.006
  31. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol. 2007 Jul; 171(1):116-23.
    View in: PubMed
    Score: 0.005
  32. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
    View in: PubMed
    Score: 0.005
  33. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.005
  34. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 2007 Jun; 28(18):2830-8.
    View in: PubMed
    Score: 0.005
  35. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
    View in: PubMed
    Score: 0.005
  36. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 Jan; 28(3):496-503.
    View in: PubMed
    Score: 0.005
  37. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 Jul; 27(19):3645-51.
    View in: PubMed
    Score: 0.005
  38. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
    View in: PubMed
    Score: 0.005
  39. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
    View in: PubMed
    Score: 0.005
  40. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.005
  41. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
    View in: PubMed
    Score: 0.005
  42. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials. 2004 Oct; 25(22):5227-37.
    View in: PubMed
    Score: 0.004
  43. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 2004 Jul; 25(16):3293-302.
    View in: PubMed
    Score: 0.004
  44. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
    View in: PubMed
    Score: 0.004
  45. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. ASAIO J. 1996 Sep-Oct; 42(5):M561-7.
    View in: PubMed
    Score: 0.003
  46. Lysine-enhanced glutaraldehyde crosslinking of collagenous biomaterials. J Biomed Mater Res. 1991 Dec; 25(12):1495-505.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.